Physician profile
Paul M Hendrix
NPI 1649249947
$1,537.98
in general payments reported to CMS, 2019-2025
17 companies · $94.80 in 2025
The $94.80 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $19.53 · 2021: $291 · 2022: $332 · 2023: $192 · 2024: $448 · 2025: $94.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $777.77 | 2020-2025 | |
| Celgene Corporation | $223.60 | 2019-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $103.30 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.88 | 2019-2024 | Xifaxan |
| Boston Scientific Corporation | $52.69 | 2019-2025 | Overstitch Nxt Endoscopic Suturing System |
| Genzyme Corporation | $49.69 | 2023-2025 | |
| Medtronic, INC. | $47.80 | 2021-2023 | Endoflip |
| Janssen Biotech, INC. | $38.17 | 2022-2023 | Simponi Aria, Remicade, Stelara |
| Allergan, INC. | $34.10 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.27 | 2021-2022 | |
| Pfizer INC. | $28.75 | 2019 | |
| Nestle Healthcare Nutrition INC. | $22.67 | 2021 | |
| Orphalan INC | $17.71 | 2024 | Cuvrior |
| Takeda Pharmaceuticals U.S.A., INC. | $17.26 | 2021 | |
| Merck Sharp & Dohme LLC | $13.32 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.